GILEAD SCIENCES, INC.

13F Filings History

Latest 13F report
Q4 2024 - Feb 13, 2025
Value $
$1.55B
Signature - Title
Andrew D. Dickinson - Executive Vice President and Chief Financial Officer
Location
Foster City, CA
Summary
This page shows a list of all the recent 13F filings made by GILEAD SCIENCES, INC.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. GILEAD SCIENCES, INC. reported 16 stock holdings with total value $1.55B as of Q4 2024. Top holdings included ACLX, GLPG, RCUS, ASMB, and MRUS.
Holdings Value